Albendazole

阿苯达唑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAlbendazole
Drug Alias NameAlbendazolum阿咪唑Proftril丙硫咪唑Albendazol +[26] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated proteins inhibitors
TargetsMicrotubule-associated proteins
Therapy Area/IndicationsIntestinal DiseasesHIV InfectionsProtozoan Infections +[10] 
Global Approved IndicationsHelminthiasis
Approved Indications in ChinaHelminthiasis
Original Approved Country/TerritoryN/A
Original Approved Date1981/01/01
Country/TerritoryBeninUnited StatesTanzania +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesInstitut De Recherche Pour Le Developpement, FranceUniversity of ZurichGlaxosmithkline Plc +[5] 
Inactive CompaniesLao Tropical And Public Health InstituteSmithkline BeechamColumbia University +[6] 
Active IndicationsIntestinal DiseasesLoiasisFilariasis +[5] 
Inactive IndicationsHIV InfectionsProtozoan InfectionsTrichuriasis +[5] 

Other Information

ATC CodeP02CA03
Related LinksWikipediaDrugBankKEGG